Cubist Systematic Strategies, LLC Medicinova Inc Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.95 - $2.54 $13,751 - $17,912	-7,052 Reduced 66.98%	3,476 $7,000
Q4 2022 Feb 14, 2023	BUY	$1.97 - $2.66 $20,740 - $28,004	10,528 New	10,528 $21,000
Q3 2021 Nov 15, 2021	SELL	$3.4 - $4.24 $110,704 - $138,054	-32,560 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.76 - $5.14 $122,425 - $167,358	32,560 New	32,560 $138,000
Q1 2020 May 15, 2020	SELL	$2.9 - $6.97 $31,320 - $75,276	-10,800 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$6.48 - $8.76 $69,984 - $94,608	10,800 New	10,800 $73,000

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $106M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.